Glenmark's US unit launched Calcium Gluconate Injection USP, strengthening its injectables business.

Glenmark Pharmaceuticals LimitedGLENMARK · Filed with the exchange

This product enters a US market with estimated annual sales of ~$69.9 million (~₹580 Cr), enhancing its hospital portfolio.

No comments yet. Be the first.

More from Glenmark Pharmaceuticals Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.